Clene Nanomedicine
Clinical-stage biopharmaceutical company developing nanotherapeutics for neurodegenerative and infectious disease indications. Activities described on the site include preclinical research (in vitro and animal models), manufacturing of metal-based nanocrystals and ionic metal solutions via a patented electrochemical production process, execution of clinical trials in neurology (ALS, MS, PD), and operation of expanded/early access programs in partnership with academic centers and a telehealth provider.
Industries
Nr. of Employees
medium (51-250)
Clene Nanomedicine
SALT LAKE CITY, Uttarākhand, United States
Patents
Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-11000042-B2
View DetailsGold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
US-10980832-B2
View DetailsGold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
US-10449217-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-10441608-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-10092007-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-9743672-B2
View Details
Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-11000042-B2
View DetailsGold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
US-10980832-B2
View DetailsGold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
US-10449217-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-10441608-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-10092007-B2
View DetailsContinuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
US-9743672-B2
View DetailsProducts
CNM-Au8
Oral suspension of clean-surfaced, catalytically-active gold nanocrystals developed as a potential disease‑modifying candidate for ALS, multiple sclerosis, and Parkinson’s disease.
CNM-ZnAg
Zinc‑silver ionic solution under development with reported antiviral and antimicrobial properties.
CNM-AgZn17
Topical gel polymer suspension of silver and zinc ions being developed for treatment of infectious disease and accelerated wound healing.
CNM-PtAu7
Gold‑platinum nanotherapeutic with initial in vitro research showing activity across multiple tumor cell lines.
CNM-Au8
Oral suspension of clean-surfaced, catalytically-active gold nanocrystals developed as a potential disease‑modifying candidate for ALS, multiple sclerosis, and Parkinson’s disease.
CNM-ZnAg
Zinc‑silver ionic solution under development with reported antiviral and antimicrobial properties.
CNM-AgZn17
Topical gel polymer suspension of silver and zinc ions being developed for treatment of infectious disease and accelerated wound healing.
CNM-PtAu7
Gold‑platinum nanotherapeutic with initial in vitro research showing activity across multiple tumor cell lines.
Services
Administration of individual and multiple‑patient expanded/early access programs for investigational therapeutics, including protocol development, IRB submissions, and coordination with treating physicians and institutions.
Virtual clinical operations for remote patient visits, home-based sample collection, and remote data capture in collaboration with a tele-neurology provider.
Administration of individual and multiple‑patient expanded/early access programs for investigational therapeutics, including protocol development, IRB submissions, and coordination with treating physicians and institutions.
Virtual clinical operations for remote patient visits, home-based sample collection, and remote data capture in collaboration with a tele-neurology provider.
Expertise Areas
- Nanotherapeutics development
- Clinical trial management for neurodegenerative diseases
- Expanded access program administration
- Telehealth-enabled remote clinical operations
Key Technologies
- Electrochemical production of metal nanocrystals
- Metallic nanocrystals (gold, gold–platinum) therapeutics
- Ionic metal solutions (zinc‑silver) therapeutics
- Oral suspension formulation